Fig. 2.

Improvement in “outer retinal thickness” according to study timepoints (T0, T1, T2) in the eye treated with the Wharton’s jelly-derived mesenchymal stem cell (WJ-MSC) (Table 1, patient 1: right eye—published data: a and b are the first 6-month changes of a patient from our previous study [46]). a Before application, 85.0 μm. b At 6th month, 152.2 μm. c At 12th month, 154.1 μm